PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-05

Date Title Company
05-Jan-2026 Xironetic Appoints Brandon Strong as Chief Product Officer and Chief Research Officer ACCESS Newswire
05-Jan-2026 Black Book Research Publishes 2026 Australia Acute-Care EMR/EHR Strategic Fit Benchmark ACCESS Newswire
05-Jan-2026 Hon. Judith N. McMahon (Ret.) Joins NAM’s Esteemed Panel of Neutrals Businesswire
05-Jan-2026 Bleichmar Fonti & Auld LLP Announces New Partners Businesswire
05-Jan-2026 Moolec Science Announces Effectiveness of Share Consolidation ACCESS Newswire
05-Jan-2026 Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference Businesswire
05-Jan-2026 SpineGuard Announces its 2026 Financial Calendar Businesswire
05-Jan-2026 Digi International to Showcase Complete Embedded IoT Connectivity and Infrastructure Management Solutions at CES® 2026 Businesswire
05-Jan-2026 Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 Businesswire
05-Jan-2026 LEM Surgical Showcases the World's First "Surgical Humanoid" at CES 2026; Groundbreaking NVIDIA Physical AI Toolsets to Drive Dynamis Robotic Surgical System Development ACCESS Newswire
05-Jan-2026 4 New Year’s Resolutions to reduce drinking and live a healthier 2026 Sinclair Method UK
05-Jan-2026 The Pershing Square Foundation Launches Lotus Award in Women’s Ovarian Health Businesswire
05-Jan-2026 Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
05-Jan-2026 GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill Businesswire
05-Jan-2026 Lineage Cell Therapeutics Issues Letter to Stockholders Businesswire
05-Jan-2026 GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026 Businesswire
05-Jan-2026 Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform Businesswire
05-Jan-2026 Coya Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Frontotemporal Dementia (FTD) Businesswire
05-Jan-2026 Marea Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
05-Jan-2026 Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 Businesswire